|
Name:
Ju-Ping (Joyce) Lai
Education:
1991-95 B.S. Pharmacy, Taipei Medical University, Taiwan
1996-97 M.S. Pharmaceutics/Pharmacokinetics, Taipei Medical University, Taiwan
2003- Ph.D. Pharmacy/Pharmaceutics, The Ohio State University Columbus, OH
Mentor:
James T. Dalton, Ph.D.
Daren Knoell, Pharm.D.
Research Interests: I am working on studying small molecule candidates for cell survival via PI3K/Akt pathway to serve as a strategy for acute lung injury therapy. The current project is PTEN inhibition by PTEN inhibitors to improve wound healing in lung cells.
Publications:
Samuel K. Kulp, Ya-Ting Yang, Chin-Chun Hung, Kuen-Feng Chen, Ju-Ping Lai, Ping-Hui Tseng, Joseph W. Fowble, Patrick J. Ward, and Ching-Shih Chen. 3-Phosphoinositide-Dependent Protein Kinase-1/Akt Signaling Represents a Major Cyclooxygenase-2-Independent Target for Celecoxib in Prostate Cancer Cells. CANCER RESEARCH 64, 1444–1451, February 15, 2004
|